Irritable Bowel Syndrome Mixed
Conditions
Brief summary
This study was designed as a pilot, open-labelled study. We enrolled consecutive IBS-M patients (n=25, 19 females, 46.06 ± 13.11 years) according to Rome IV criteria. Fecal samples were obtained from all patients twice (pre- and post-intervention) and high-throughput 16S rRNA sequencing was performed. Patients were divided into two groups based on age, gender and microbiome matched. Six weeks of AI-based microbiome diet (n=14) for group 1 and standard IBS diet (Control group, n=11) for group 2 were followed. AI-based diet was designed based on optimizing a personalized nutritional strategy by an algorithm regarding individual gut microbiome features. An algorithm assessing an IBS index score using microbiome composition attempted to design the optimized diets based on modulating microbiome towards the healthy scores. Baseline and post-intervention IBS-SSS (symptom severity scale) scores and fecal microbiome analyses were compared.
Interventions
DIETARY_SUPPLEMENTPersonalized microbiome diet
The personalized nutrition model estimates the optimal micronutrient compositions for a required microbiome modulation. In this study, we computed the microbiome modulation needed for an IBS case, based on the IBS-indices generated by the machine learning models. According to that, the baseline microbiome compositions are perturbed randomly with a small probability p. Perturbed profiles are accepted with a probability proportional to the decrease in the IBS-index as suggested by Metropolis sampling. This Monte-Carlo random walk in the microbiome composition space is expected to meet a low IBS-index microbiome composition nearby the baseline microbiome composition of the patient with a minimal modulation. The personalized nutrition model, then, estimates the optimized nutritional composition needed for this individual, expecting to drive the IBS-index to lower values.
Sponsors
ENBIOSIS BIOTECHNOLOGIES
TC Erciyes University
Gazi University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosed with IBS by a medical doctor. * BMI between 18.5-39.9 kg/m2 * No hospitalization in the last 12 months. * No antibiotics use in the last 6 months. * No cancer diagnosis by a medical doctor. * No chronic complex diseases including diabetes and hypertension.
Exclusion criteria
* Not being diagnosed with IBS. * Having a diagnosed chronic disease. * Having a diagnosed mental or psychiatric disorder . * Having endocrinal disorders. * Being pregnant. * Antibiotics use in the last 6 months. * Hospitalization history in the last 12 months. * Drug use. * Being morbid obese.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| IBS-SSS change | Change is measured between the scores pre-intervention and the scores six weeks after the intervention starts | Change in IBS-SSS scores according to ROME IV criteria were assessed. |
Countries
Turkey (Türkiye)
Outcome results
None listed